Pharm'Up
The ASTER 70s trial, a phase 3 study published in The Lancet, has provided crucial new evidence...
Culturally tailored education is more than just translated materials; it’s a powerful tool for empowering patients with...
A new study published in Nature Communications has found that giving probiotic supplements to very-low-birth-weight (VLBW) preterm...
Palbociclib (Ibrance) has become a cornerstone in the treatment of advanced hormone receptor-positive (HR+), HER2-negative (HER2–) breast...
The American Academy of Pediatrics (AAP) has issued its own 2025 child and adolescent immunization schedule, a...
A study published in Frontiers in Cellular and Infection Microbiology reveals how non-pharmaceutical interventions (NPIs) during the...
A new 52-week study has provided strong evidence that tocilizumab-anoh (Avtozma), a biosimilar of the reference drug...
A new study published in JAMA Pediatrics has uncovered why some children with asthma continue to suffer...
The FDA has granted approval to donidalorsen (Dawnzera; Ionis Pharmaceuticals Inc.), marking a significant advancement in the...
A large-scale, real-world study published in Blood Advances challenges the long-held assumption that regular immunoglobulin replacement therapy...
